Abbott Laboratories buy Stifel Nicolaus
Start price
23.01.25
/
50%
€113.50
Target price
23.01.26
€129.61
Performance (%)
-19.76%
End price
24.01.26
€91.07
Summary
This prediction ended on 24.01.26 with a price of €91.07. The prediction for Abbott Laboratories disappointed with a performance of -19.76%. Stifel_Nicolaus has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | 3.393% | 3.393% | -24.613% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $130.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.06
17.04.25
17.04.25
€127.60
17.04.26
17.04.26
-14.44%
27.02.26
27.02.26
